Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marsh & Mclennan Companies (MRSH) Dividends Paid - Common (2016 - 2025)

Marsh & Mclennan Companies (MRSH) has disclosed Dividends Paid - Common for 17 consecutive years, with -$810.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Dividends Paid - Common fell 4962.5% year-over-year to -$810.0 million, compared with a TTM value of $35.0 million through Sep 2025, down 72.22%, and an annual FY2024 reading of $40.0 million, down 71.22% over the prior year.
  • Dividends Paid - Common was -$810.0 million for Q3 2025 at Marsh & Mclennan Companies, down from $789.0 million in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $789.0 million in Q2 2025 and bottomed at -$810.0 million in Q3 2025.
  • Average Dividends Paid - Common over 5 years is $12.7 million, with a median of $21.0 million recorded in 2025.
  • Peak annual rise in Dividends Paid - Common hit 11650.0% in 2021, while the deepest fall reached 11375.0% in 2021.
  • Year by year, Dividends Paid - Common stood at $9.0 million in 2021, then dropped by 22.22% to $7.0 million in 2022, then soared by 1628.57% to $121.0 million in 2023, then tumbled by 71.07% to $35.0 million in 2024, then tumbled by 2414.29% to -$810.0 million in 2025.
  • Business Quant data shows Dividends Paid - Common for MRSH at -$810.0 million in Q3 2025, $789.0 million in Q2 2025, and $21.0 million in Q1 2025.